Location History:
- Omaha, NE (US) (2013)
- Omaha, MI (US) (2013)
Company Filing History:
Years Active: 2013
Title: Innovations by Gary D. Krzyzanowski
Introduction
Gary D. Krzyzanowski is an accomplished inventor based in Omaha, NE. He has made significant contributions to the field of medical technology, particularly in the area of glycated hemoglobin controls. With a total of 2 patents, his work has the potential to impact diabetes management and patient care.
Latest Patents
Gary's latest patents include "Cis di-ahl modified controls for glycated hemoglobin S-A1c derived from healthy blood cells" and "Method of preparing controls for glycated hemoglobin S-A1c derived from healthy blood cells." The first patent describes a composition comprising red blood cells in an aqueous suspension medium, where more than 6 percent by weight of the hemoglobin is S-A1c glycated hemoglobin. This invention aims to provide a reliable method for measuring glycated hemoglobin levels using various analytical techniques. The second patent outlines a method for increasing the concentration of S-A1c glycated hemoglobin in red blood cells, utilizing a suspension medium containing mannose under specific conditions.
Career Highlights
Gary is currently employed at Streck, Inc., where he continues to innovate and develop new solutions in the medical field. His expertise in glycated hemoglobin controls has positioned him as a key figure in advancing diagnostic methods for diabetes.
Collaborations
Gary has collaborated with notable colleagues such as Kausik Das and Joel Lechner, contributing to the development of innovative solutions in his field.
Conclusion
Gary D. Krzyzanowski's contributions to medical technology through his patents demonstrate his commitment to improving healthcare outcomes. His work in glycated hemoglobin controls is a testament to the importance of innovation in the medical field.